Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Amgen Inc.

Start price
Target price
Perf. (%)
€156.95
15.08.17
€117.26
11.09.17
6.03%
11.09.17

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€28.97
07.08.17
€46.64
25.06.19
-44.08%
25.06.19

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€116.04
18.07.17
€130.00
08.12.17
4.39%
08.12.17

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€113.94
19.04.17
€125.00
26.06.17
7.94%
26.06.17

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.11.16
€85.00
18.04.17
8.26%
18.04.17

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
10.71%
13:07

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.50
05.08.16
€85.69
03.01.18
-3.74%
03.01.18

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€140.86
09.06.16
€180.40
02.04.18
11.59%
02.04.18

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€38.60
03.05.16
€50.00
15.07.16
4.77%
15.07.16

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
Top 10 in its market
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€80.73
29.04.16
€100.00
28.03.17
-20.63%
28.03.17

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€63.10
24.03.16
€90.00
08.08.16
16.05%
08.08.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€329.64
15.03.16
€517.75
08.08.16
15.29%
08.08.16

Could be worthwhile Investment >10% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.79
08.02.16
€100.00
28.04.16
14.98%
28.04.16

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€244.61
04.02.16
€387.86
08.02.16
-6.48%
08.02.16

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€99.55
04.11.15
€115.00
29.01.16
-22.56%
29.01.16

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.93
13.10.15
€90.20
04.01.16
4.66%
04.01.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€136.74
20.09.15
€151.54
21.03.16
-2.83%
21.03.16

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€283.95
09.08.15
€320.77
21.07.16
-16.64%
21.07.16

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€101.67
27.07.15
€144.32
15.06.17
-39.55%
15.06.17

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€369.85
21.07.15
€387.86
18.07.16
-36.52%
18.07.16

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€87.59
30.06.15
€95.00
16.07.15
6.07%
16.07.15

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€101.31
08.06.15
€107.00
11.09.17
-25.69%
11.09.17

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€65.85
05.05.15
€83.00
22.07.15
19.78%
22.07.15

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€93.74
04.05.15
€110.00
29.06.15
11.35%
29.06.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€64.20
15.03.15
€68.00
15.09.15
-17.70%
15.09.15